NASDAQ

UroGen Pharma Ltd. - Ordinary Shares (URGN)

♥ 646 Thanks from members

Live price chart, market sentiment, and community perspectives for UroGen Pharma Ltd. (NASDAQ: URGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Arie BelldegrunFounder: Avraham Ben-NunLeadership: Liz Barrett (President and CEO)Leadership: Sean Whelan (CFO)Holder: Pfizer Inc.Holder: The Vanguard GroupHolder: RA Capital ManagementJelmytoUGN-102RTGel Technology#URGN#UroGen Pharma#Jelmyto#Urology Biotech#NASDAQ URGN